• Explore /
  • Poster
  • / Correlation of germ-line <em>BRCA2</em> mutations with aggressive prostate cancer and  outcome.

Correlation of germ-line BRCA2 mutations with aggressive prostate cancer and  outcome.

Abstract Poster

Authors

null

E. Castro

The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom

E. Castro , C. L. Goh , D. Olmos , D. Leongamornlert , M. Tymrakiewicz , N. Mahmud , T. Dadaev , K. Govindasami , M. Guy , L. OBrien , E. Sawyer , A. Hall , R. Wilkinson , Z. Kote-Jarai , R. A. Eeles

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Cancer Prevention/Epidemiology

Track

Cancer Prevention/Epidemiology

Sub Track

Cancer Genetics

Citation

J Clin Oncol 29: 2011 (suppl; abstr 1517)

Abstract #

1517

Poster Bd #

9

Abstract Disclosures

Similar Posters

First Author: Christos Mikropoulos

Poster

2012 ASCO Annual Meeting

Detecting prostate cancer in<I> BRCA1</I> and <I>BRCA2 </I>mutation carriers: A role for EN2?

Detecting prostate cancer in BRCA1 and BRCA2 mutation carriers: A role for EN2?

First Author: Emma Killick

First Author: Sachdev P. Thomas

First Author: Arpit Rao